Beizray Injection, Solution
Product Images NDC 83513-009

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Beizray (NDC 83513-009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zhuhai Beihai Biotech Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Albumin-final (Albumin Final)

Albumin-final (Albumin Final)
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
FDA Label Image

Figure-10 (Figure 10)

Figure-10 (Figure 10)
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
This is a table showing the survival probability in percentage over different time intervals measured in months. The survival probability starts at 100% and decreases as the time in months increases from 6 to 48.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
This description provides information on cumulative probability, overall survival rate with a Log-rank p-value of 0.010, and survival time in months. The text seems to be related to analyzing survival data or outcomes in a research study or clinical trial.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
FDA Label Image

Figure-6 (Figure 6)

Figure-6 (Figure 6)
FDA Label Image

Figure-7 (Figure 7)

Figure-7 (Figure 7)
FDA Label Image

Figure-8 (Figure 8)

Figure-8 (Figure 8)
FDA Label Image

Figure-9 (Figure 9)

Figure-9 (Figure 9)
FDA Label Image

Kit-label-9-27 (Kit Label 9 27)

Kit-label-9-27 (Kit Label 9 27)
This text appears to be a detailed description of a medication named BEIZRAY (docetaxel) injection. It provides information such as dosage, administration instructions, recommended storage conditions, and precautions. The medication is available in vials containing 80 mg of docetaxel in 4 mL solution (20 mg/mL) for intravenous use. The text also mentions the NDC code, color-coding with corresponding hexadecimal values, and warnings about the hazardous nature of the drug. It emphasizes the correct preparation and administration process, specifying the use of 0.9% Sodium Chloride injection solution for dilution. Overall, this text serves as essential information for healthcare professionals regarding the proper usage of BEIZRAY in intravenous infusion.*
FDA Label Image

Kit-pic (Kit Pic)

Kit-pic (Kit Pic)
FDA Label Image

Structure (Structure)

Structure (Structure)
FDA Label Image

Vial-label-9-29 (Vial Label 9 29)

Vial-label-9-29 (Vial Label 9 29)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.